Sweden-based SyntheticMR has received 510(k) clearance from the US Food and Drug Administration (FDA) for its multi-contrast magnetic resonance (MR) technique, MAGiC.

Magnetic Resonance Image Compilation (MAGiC) is developed as an acquisition technique to allow clinicians to modify image contrast after completing a scan and allowing them to view multiple different contrasts derived from a single scan.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The changes of the image paves the way for clinicians to improve their diagnosis of ailments.

"This study proves that this technique can improve the way clinicians conduct neuro scans and diagnose their patients."

It also allows the flexibility to change images retrospectively saving time, causing fewer rescans and saving costs.

MAGiC is the integrated and customised variant of SyntheticMR’s SyMRI IMAGE software marketed by GE Healthcare under a license agreement.

SyMRI IMAGE assists in optimising workflows and reduces scan times using synthetic MRI. Its tools enable fast and easy viewing, as well as handling of images.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

SyntheticMR’s partner GE Healthcare undertook a blinded, mulit-centre, multi-reader clinical study to compare MAGiC to conventional MRI, which suggested comparable results of the image quality of MAGiC with that of the conventional images at a fraction of the scan time.

GE Healthcare MR president and CEO Eric Stahre said: “This study proves that this technique can improve the way clinicians conduct neuro scans and diagnose their patients.

“Neuro scans are approximately 30% of all MR scans; therefore MAGiC could have a tremendous impact on the MR community.